ACC.24 — Investigator, Dr Felix Böhm (Danderyd Hospital, SE) joins us to discuss the findings from a study investigating fractional flow reserve-guided complete or culprit-only percutaneous coronary intervention (PCI) in patients with ST-elevation myocardial infarction (MI).
1542 patients were enrolled in the trial, who were randomized 1:1 to receive either FFR-guided PCI of non-culprit lesions during index hospitalisation, or initial conservative management of non-culprit lesions. The primary endpoint was a composite of death, MI or unplanned revascularization.
Findings suggest that when compared to culprit-lesion-only PCI, FFR-guided complete non-culprit revascularization did not reduce death, MI or unplanned revascularization (HR 0.93; p=0.53). There was an observed benefit to reducing any revascularization, both planned and unplanned, however there was a higher incidence of stent thrombosis via the complete strategy. No differences in stroke, bleeding, heart failure or acute kidney injury were apparent.
Interview Questions:
- What is the importance of this study?
- What was the study design and patient population?
- What are the key findings?
- How should these findings impact clinical practice?
- What are your take-home messages?
- What further study is needed?
Recorded onsite at the ACC Conference in Atlanta, 2024.
For more content from ACC.24 head to the Late-breaking Science Video Collection.
Support: This is an independent interview conducted by Radcliffe Cardiology.
Editors: Jordan Rance, Mirjam Boros
Video Specialists: Dan Brent, Tom Green, Mike Knight
Comments